Lion's Pride Volume 13 (Spring 2020) Volume 13 (Spring 2020) | Page 27

Disease Control and Prevention (CDC) and a study published on Lancet Global Health indicated that the rapid increase of PWID in the U.S. is largely associated with the abuse of prescription opioids (CDC, 2019a; Degenhardt et al., 2017). The data from the National Survey on Drug Use and Health (2007) showed that between 2002 and 2005, there were an average of 424,000 PWID in the U.S. However, in 2018, the CDC (2019a) indicated that the number of PWID had already increased to 775,000. The actual number of PWID may be much greater than these numbers, since some PWID may not report their injection behavior due to their drug use being illicit or due to the stigma of such drug use. The use of injection drugs is also a risk factor correlated with unstable housing and homelessness. In some cities in the United States, such as Seattle, Los Angeles, San Francisco, and Philadelphia, there is a big proportion of injection drug users who are homeless or in unstable housing (HIV/AIDS Epidemiology Unit, Public Health –Seattle & King County and the Infectious Disease Assessment Unit, & Washington State Department of Health, 2019; Quinn, Chu, Wenger, Bluthenthal, & Kral, 2014; Mirzazadeh et al., 2018; Larson, Padron, Mason, & Bogaczyk, 2017). Clearly, the issue of intravenous drug misuse among PWID is serious. Not only are the people from this group at high health risks, but also their families and communities.